Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Brain-made chemicals can control nerve cell function differently in various parts of a mouse's brain, which may help us understand neurological conditions.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Pertussis toxin may contribute to hair loss in alopecia areata.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Immunoadsorption successfully treated a man's resistant polymyositis.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.